ALLR
Allarity Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$18.98M
P/E Ratio
—
EPS
$-0.78
Beta
0.24
52W High
$2.06
52W Low
$0.61
50-Day MA
$1.05
200-Day MA
$1.19
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Allarity Therapeutics Inc
Allarity Therapeutics A / S develops various therapeutic candidates for the treatment of cancer using complementary drug-specific diagnostics (cDx) generated by its drug response prediction technology. The company is headquartered in Horsholm, Denmark.
Fundamentals
| Revenue (TTM) | 320,000 |
| Gross Profit (TTM) | 320,000 |
| EBITDA | $-12.60M |
| Operating Margin | -912.00% |
| Return on Equity | -103.80% |
| Return on Assets | -38.50% |
| Revenue/Share (TTM) | $0.02 |
| Book Value | $0.61 |
| Price-to-Book | 1.93 |
| Price-to-Sales (TTM) | 59.30 |
| EV/Revenue | 17.78 |
| EV/EBITDA | -0.08 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $16.08M |
| Float | $15.79M |
| % Insiders | 3.51% |
| % Institutions | 8.17% |
Data last updated: 4/7/2026